ArticlePloS one2023

Repurposing of approved drugs for targeting CDK4/6 and aromatase protein using molecular docking and molecular dynamics studies.

Fatima A Yousif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.